Marijuana Stocks: A Clinical Stage Company Presents Growth OpportunitiesIt’s clear that companies like Gilead or Merck don’t have any plans on slowing down the... Marijuana Stocks Newsletter – August 27, 2018

Marijuana Stocks: A Clinical Stage Company Presents Growth Opportunities
It’s clear that companies like Gilead or Merck don’t have any plans on slowing down the M&A trend anytime soon. Gilead’s CEO has even said that the company is “quite interested in things that would augment cellular therapy.”

For this reason many investors have started to search for “the next early clinical stage” opportunity. What if we told you that some of the most experienced people in the biotechnology sector have made a move to join a company that, right now, is quietly beginning to develop major breakthroughs for things like pain management and cancer?
Full Report


GTEC Holdings Ltd. (GTEC.V) (GGTTF) Announces Supply Agreement with Namaste Technologies & Cannmart
GTEC Holdings Ltd. (“GTEC” or the “Company”) (GTEC.V) (GGTTF) is pleased to announce that it has signed a cannabis supply agreement (the “Supply Agreement”) with Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) whereby Namaste’s wholly owned subsidiary, Cannmart Inc. (“Cannmart”) will purchase cannabis flower and oil from GTEC for resale on Cannmart’s on-line platform.

Click Here For More Details


Is This What Canada’s Legalization Means For Pot Stocks?
A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry.
Click Here For Full Release


Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GTEC Holdings Inc., Midam is being paid $63,333 per month from the company for a total of 12 months and has received ZERO shares of GTEC Holdings Inc. for a duration of beginning July 10, 2018 and ending July 10, 2019. We may buy or sell additional shares of (GTEC) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )